Sandhill Capital Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-148,886
Closed -$11.8M 83
2015
Q4
$11.8M Buy
148,886
+294
+0.2% +$23.2K 3.74% 14
2015
Q3
$10.5M Buy
148,592
+3,254
+2% +$268K 3.49% 14
2015
Q2
$13.1M Buy
145,338
+34,978
+32% +$3.37M 4.02% 10
2015
Q1
$11.1M Buy
110,360
+4,153
+4% +$419K 3.77% 13
2014
Q4
$10.7M Buy
106,207
+1,222
+1% +$122K 3.62% 14
2014
Q3
$10.1M Buy
104,985
+2,435
+2% +$231K 3.6% 13
2014
Q2
$9.55M Buy
102,550
+1,177
+1% +$103K 3.46% 15
2014
Q1
$8.43M Buy
101,373
+3,156
+3% +$256K 3.19% 18
2013
Q4
$8.23M Buy
98,217
+6,085
+7% +$496K 3.29% 19
2013
Q3
$6.84M Buy
92,132
+2,440
+3% +$183K 3.08% 19
2013
Q2
$7.11M Buy
+89,692
New +$7.19M 3.52% 14

Other funds holding MJN

Sandhill Capital Partners's MJN Position: Q1 2016 in Review

Sandhill Capital Partners sold out of Mead Johnson Nutrition Company (MJN) in Q1 2016, closing a stake of 148,886 shares — an estimated $11.8M sold.

Sandhill Capital Partners first reported a position in MJN in Q2 2013 and held it in 11 quarters. The position peaked at $13.1M in Q2 2015. 562 funds tracked by Wall St. Rank hold MJN as of Q1 2016.

  • Sandhill Capital Partners reported no remaining Mead Johnson Nutrition Company position as of Q1 2016 after selling out during the quarter.
  • Sandhill Capital Partners sold 148,886 Mead Johnson Nutrition Company shares in Q1 2016, an estimated $11.8M.
  • Sandhill Capital Partners first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 11 quarters.
  • Sandhill Capital Partners's Mead Johnson Nutrition Company position peaked at $13.1M in Q2 2015.
  • 562 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2016.

Based on Sandhill Capital Partners's 13F filing for Q1 2016, filed 9 May 2016.